期刊文献+

性激素对骨密度及骨形态影响的研究进展 被引量:7

Progress in the effects of sex steroids on bone mineral density and morphology
原文传递
导出
摘要 性激素在骨骼生长发育及维持方面发挥重要作用.年轻成年男性比女性骨强度及骨结构更优,是雄激素充分发挥作用造成的,包括雄激素本身以及转化为雌二醇和双氢睾酮促进骨骼生长.随着年龄增长,男性出现骨量下降较女性更晚,与雌激素水平下降有关.本文将总结成年两性骨骼生长及骨量维持的差异及原因,并以病理模型作为支持,总结性激素对骨密度及骨形态影响的研究进展. Sex steroids play an important role in the growth,development,and maintenance of the bone.Sex differences are observed in bone mass growth.Bone structure and strength in young males are stronger than young females,which are results of the fully utilization of androgen containing testosterone,its aromatization and its reduction products.As male and female growing older,the reduction in bone mass of males happens later than that of females,which are result of the more moderate decrease of estrogen in males.Our review is to summarize the effects of bone metabolism differences between males and females based on several clinical pathological models and to review the latest researches in this field.
作者 张睿 伍学焱 Zhang Rui;Wu Xueyan(Laboratory of Endocrinology,Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China)
机构地区 中国医学科学院
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2019年第11期986-990,共5页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金(81771576)。
关键词 性激素 骨密度 骨形态 Sex steroid Bone mineral density Bone morphology
  • 相关文献

参考文献1

二级参考文献189

  • 1Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, et al. Androgens and bone. Endocr Rev 2004, 25: 389-425. 被引量:1
  • 2Laurent M, Gielen E, Claessens F, Boonen S, Vandersehueren D. Osteoporosis in older men: recent advances in pathophysiology and treatment. Best Pract Res Clin Endocrinol Metab 2013, 27: 527-39. 被引量:1
  • 3Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006, 17: 1726-33. 被引量:1
  • 4Kanis Ja, Oden A, Mccloskey EV, Johansson H, Wahl DA, et al. IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 2012, 23: 2239-56. 被引量:1
  • 5Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007, 22: 465-75. 被引量:1
  • 6Tarride JE, Guo N, Hopkins R, Leslie WD, Morin S, etal. The burden of illness of osteoporosis in Canadian men. J Bone Miner Res 2012, 27: 2830-8. 被引量:1
  • 7Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, etal. The burden of illness of osteoporosis in Canada. Osteoporos Int 2012, 23: 2591-600. 被引量:1
  • 8Frost M, Wraae K, Abrahamsen B, Hoiberg M, Hagen C, et al. Osteoporosis and vertebral fractures in men aged 60-74 years. Age Ageing 2012, 41: 171-7. 被引量:1
  • 9Nurmi-Luthje I, Sund R, Juntunen M, Luthje P. Post-hip fracture use of prescribed calcium plus vitamin d or vitamin d supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Miner Res 2011, 26: 1845-53. 被引量:1
  • 10Wastesson JW, Ringback Weitoft G, Parker MG, Johnell K, educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study. Osteoporos Int 2013, 24: 433-42. 被引量:1

共引文献3

同被引文献70

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部